2016
TRUS Biopsy: Is There Still a Role?
Leapman M, Shinohara K. TRUS Biopsy: Is There Still a Role? 2016, 53-67. DOI: 10.1007/978-3-319-21485-6_4.Peer-Reviewed Original ResearchProstate biopsyLateral peripheral zoneTRUS prostate biopsyInitial negative biopsyBiopsy-related complicationsCancer detection rateNovel serum biomarkersNegative predictive valueTRUS-BxPower Doppler imagingClinical parametersNegative biopsySextant biopsyGleason scoreSerum biomarkersUltrasonographic parametersPrognostic informationSuspicious lesionsBiopsy strategyBiopsyDoppler imagingPredictive valueBenign tissueContrast enhancementPeripheral zone
2001
SCATTER FACTOR-HEPATOCYTE GROWTH FACTOR ELEVATION IN THE SERUM OF PATIENTS WITH PROSTATE CANCER
NAUGHTON M, PICUS J, ZHU X, CATALONA W, VOLLMER R, HUMPHREY P. SCATTER FACTOR-HEPATOCYTE GROWTH FACTOR ELEVATION IN THE SERUM OF PATIENTS WITH PROSTATE CANCER. Journal Of Urology 2001, 165: 1325-1328. DOI: 10.1097/00005392-200104000-00078.Peer-Reviewed Original ResearchMetastatic prostate cancerProstate cancerMetastatic diseaseHepatocyte growth factorPatient ageSerum levelsNegative sextant prostate biopsiesProstate-specific antigen levelHuman prostate cancer cell linesAvailable enzyme-linked immunosorbentSextant prostate biopsySpecific antigen levelsNegative sextant biopsiesProstate cancer cell linesSera of patientsMethods Serum samplesImportant serum markerLogistic regression analysisEnzyme-linked immunosorbentCancer cell linesLocalized cancerRadiographic evidenceSerum markersAntigen levelsSextant biopsySCATTER FACTOR-HEPATOCYTE GROWTH FACTOR ELEVATION IN THE SERUM OF PATIENTS WITH PROSTATE CANCER
NAUGHTON M, PICUS J, ZHU X, CATALONA W, VOLLMER R, HUMPHREY P. SCATTER FACTOR-HEPATOCYTE GROWTH FACTOR ELEVATION IN THE SERUM OF PATIENTS WITH PROSTATE CANCER. Journal Of Urology 2001, 165: 1325-1328. PMID: 11257710, DOI: 10.1016/s0022-5347(01)69893-8.Peer-Reviewed Original ResearchConceptsMetastatic prostate cancerProstate cancerMetastatic diseaseHepatocyte growth factorPatient ageSerum levelsNegative sextant prostate biopsiesProstate-specific antigen levelHuman prostate cancer cell linesAvailable enzyme-linked immunosorbentSextant prostate biopsySpecific antigen levelsNegative sextant biopsiesProstate cancer cell linesSera of patientsImportant serum markerLogistic regression analysisEnzyme-linked immunosorbentCancer cell linesLocalized cancerRadiographic evidenceSerum markersAntigen levelsSextant biopsyProstate biopsy
1998
INCIDENCE AND CLINICAL SIGNIFICANCE OF FALSE-NEGATIVE SEXTANT PROSTATE BIOPSIES
RABBANI F, STROUMBAKIS N, KAVA B, COOKSON M, FAIR W. INCIDENCE AND CLINICAL SIGNIFICANCE OF FALSE-NEGATIVE SEXTANT PROSTATE BIOPSIES. Journal Of Urology 1998, 159: 1247-1250. PMID: 9507846, DOI: 10.1016/s0022-5347(01)63574-2.Peer-Reviewed Original ResearchConceptsSextant prostate biopsyFalse-negative biopsiesProstate biopsyClinical significancePathological parametersRadical prostatectomyRelapse-free survival rateNeoadjuvant hormonal therapyInitial clinical stagePositive repeat biopsyHormonal therapyMost patientsPatients 27Relapse rateRepeat biopsyClinical parametersClinical stageSextant biopsyTrue incidenceTreatment modalitiesSignificant cancerProstate cancerHigh incidenceBiopsySurvival rateINCIDENCE AND CLINICAL SIGNIFICANCE OF FALSE-NEGATIVE SEXTANT PROSTATE BIOPSIES
RABBANI F, STROUMBAKIS N, KAVA B, COOKSON M, FAIR W. INCIDENCE AND CLINICAL SIGNIFICANCE OF FALSE-NEGATIVE SEXTANT PROSTATE BIOPSIES. Journal Of Urology 1998, 159: 1247-1250.. DOI: 10.1097/00005392-199804000-00047.Peer-Reviewed Original ResearchSextant prostate biopsyFalse-negative biopsiesProstate biopsyClinical significancePathological parametersRadical prostatectomyRelapse-free survival rateNeoadjuvant hormonal therapyInitial clinical stagePositive repeat biopsyHormonal therapyMost patientsPatients 27Relapse rateRepeat biopsyClinical parametersClinical stageSextant biopsyTrue incidenceTreatment modalitiesSignificant cancerProstate cancerHigh incidenceAbstract PurposeBiopsy
1997
Clinical significance of repeat sextant biopsies in prostate cancer patients
Stroumbakis N, Cookson M, Reuter V, Fair W. Clinical significance of repeat sextant biopsies in prostate cancer patients. Urology 1997, 49: 113-118. PMID: 9123730, DOI: 10.1016/s0090-4295(97)00178-7.Peer-Reviewed Original ResearchConceptsProstate-specific antigenOrgan-confined rateMargin-positive rateProstate cancerPSA densityRebiopsy resultsRepeat biopsySextant biopsyFinal surgical margin statusRandom systematic core biopsiesGreater prostate volumeNegative repeat biopsyAndrogen deprivation therapySurgical margin statusLower clinical stageProstate cancer patientsSignificant prostate cancerBiopsy-proven prostate cancerDeprivation therapyPositive rebiopsyConsecutive patientsInitial biopsyMargin statusProstate volumeT stage
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply